Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Carlsmed (CARL) EBIT Margin (2024 - 2025)

Carlsmed (CARL) has disclosed EBIT Margin for 2 consecutive years, with 69.11% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, EBIT Margin rose 4891.0% year-over-year to 69.11%, compared with a TTM value of 50.7% through Dec 2025, changed N/A, and an annual FY2025 reading of 60.53%, up 2827.0% over the prior year.
  • EBIT Margin was 69.11% for Q3 2025 at Carlsmed, down from 45.74% in the prior quarter.
  • Across five years, EBIT Margin topped out at 45.74% in Q2 2025 and bottomed at 118.01% in Q3 2024.